Omnicell OMCL Stock
Omnicell Price Chart
Omnicell OMCL Financial and Trading Overview
| Omnicell stock price | 33.57 USD |
| Previous Close | 72.22 USD |
| Open | 72.82 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 900 |
| Day's Range | 72.28 - 73.86 USD |
| 52 Week Range | 46.11 - 125.17 USD |
| Volume | 385.75K USD |
| Avg. Volume | 401.66K USD |
| Market Cap | 3.26B USD |
| Beta (5Y Monthly) | 0.891901 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.43 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.5 USD |
OMCL Valuation Measures
| Enterprise Value | 3.53B USD |
| Trailing P/E | N/A |
| Forward P/E | 29.044176 |
| PEG Ratio (5 yr expected) | 3.6 |
| Price/Sales (ttm) | 2.5716696 |
| Price/Book (mrq) | 2.8527474 |
| Enterprise Value/Revenue | 2.785 |
| Enterprise Value/EBITDA | 78.868 |
Trading Information
Omnicell Stock Price History
| Beta (5Y Monthly) | 0.891901 |
| 52-Week Change | -32.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 125.17 USD |
| 52 Week Low | 46.11 USD |
| 50-Day Moving Average | 67.04 USD |
| 200-Day Moving Average | 64.29 USD |
OMCL Share Statistics
| Avg. Volume (3 month) | 401.66K USD |
| Avg. Daily Volume (10-Days) | 365.61K USD |
| Shares Outstanding | 45.08M |
| Float | 44.32M |
| Short Ratio | 7.16 |
| % Held by Insiders | 1.38% |
| % Held by Institutions | 102.80% |
| Shares Short | 3.2M |
| Short % of Float | 8.27% |
| Short % of Shares Outstanding | 7.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.38% |
| Operating Margin (ttm) | -1.050% |
| Gross Margin | 45.09% |
| EBITDA Margin | 3.53% |
Management Effectiveness
| Return on Assets (ttm) | -0.38% |
| Return on Equity (ttm) | -1.58% |
Income Statement
| Revenue (ttm) | 1.27B USD |
| Revenue Per Share (ttm) | 28.45 USD |
| Quarterly Revenue Growth (yoy) | -8.79% |
| Gross Profit (ttm) | 596.71M USD |
| EBITDA | 44.76M USD |
| Net Income Avi to Common (ttm) | -17565000 USD |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 340.41M USD |
| Total Cash Per Share (mrq) | 7.55 USD |
| Total Debt (mrq) | 615.07M USD |
| Total Debt/Equity (mrq) | 53.83 USD |
| Current Ratio (mrq) | 2.06 |
| Book Value Per Share (mrq) | 25.351 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 106.55M USD |
| Levered Free Cash Flow (ttm) | 82.54M USD |
Profile of Omnicell
| Country | United States |
| State | CA |
| City | Santa Clara |
| Address | 2625 Augustine Drive |
| ZIP | 95054 |
| Phone | 650 251 6100 |
| Website | https://www.omnicell.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 3830 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
Q&A For Omnicell Stock
What is a current OMCL stock price?
Omnicell OMCL stock price today per share is 33.57 USD.
How to purchase Omnicell stock?
You can buy OMCL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Omnicell?
The stock symbol or ticker of Omnicell is OMCL.
Which industry does the Omnicell company belong to?
The Omnicell industry is Health Information Services.
How many shares does Omnicell have in circulation?
The max supply of Omnicell shares is 45.93M.
What is Omnicell Price to Earnings Ratio (PE Ratio)?
Omnicell PE Ratio is 78.06976000 now.
What was Omnicell earnings per share over the trailing 12 months (TTM)?
Omnicell EPS is 0.43 USD over the trailing 12 months.
Which sector does the Omnicell company belong to?
The Omnicell sector is Healthcare.
Omnicell OMCL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Composite Total Return XCMP | 29137.78 USD — |
+0.62
|
— — | 29019.72 USD — | 29409.52 USD — | — - | — — |
| US Tech US 700 Small Cap Value I NQUS700SCV | 2218.95 USD — |
+0.1
|
— — | 2199.62 USD — | 2221.97 USD — | — - | — — |
| US Tech CTA Artificial Intellige NQROBO | 1965.06 USD — |
+1.6
|
— — | 1935.84 USD — | 1968.68 USD — | — - | — — |
| US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
| US Tech US 700 Small Cap Value N NQUS700SCVN | 2516.4 USD — |
+0.1
|
— — | 2494.48 USD — | 2519.82 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2566.34 USD — |
+0.47
|
— — | 2546.3 USD — | 2571.79 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11620.1 USD — |
+0.59
|
— — | 11575.56 USD — | 11733.88 USD — | — - | — — |
- {{ link.label }} {{link}}


